Theraclone Sciences, Inc.
Records under this name other than patents Theraclone Sciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Theraclone Sciences, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,920,111 | Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity now held by International Aids Vaccine Initiative In force · High confidence | In force | High confidence | |
| US 10,239,934 | Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity now held by International Aids Vaccine Initiative In force · Medium confidence | In force | Medium confidence | |
| US 10,407,493 | Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity now held by International Aids Vaccine Initiative In force · Medium confidence | In force | Medium confidence | |
| US 10,865,234 | Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity now held by International Aids Vaccine Initiative In force · Low confidence | In force | Low confidence | |
| US 12,018,067 | Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity now held by International Aids Vaccine Initiative, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 12,312,396 | Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity now held by International Aids Vaccine Initiative, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 11,584,789 | Monoclonal Antibodies Directed Against Trimeric Forms of the HIV-1 Envelope Glycoprotein with Broad and Potent Neutralizing Activity now held by International Aids Vaccine Initiative In force · Medium confidence | In force | Medium confidence | |
| US 9,464,131 | Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) GP120-Specific Monoclonal Antibody. now held by The Scripps Research Institute In force · High confidence | In force | High confidence | |
| US 10,836,811 | Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) GP120-Specific Monoclonal Antibody now held by International Aids Vaccine Initiative In force · High confidence | In force | High confidence | |
| US 11,845,789 | Methods of Treating HIV-1 Infection Utilizing Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) GP120-Specific Monoclonal Antibodies now held by The Scripps Research Institute In force · High confidence | In force | High confidence |